NPI: 1578715710 · OLYMPIA, WA 98502 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/21/2008
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 10/21/2008 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,366 | $191K |
| 2019 | 6,928 | $256K |
| 2020 | 8,843 | $463K |
| 2021 | 7,532 | $356K |
| 2022 | 5,332 | $307K |
| 2023 | 3,615 | $303K |
| 2024 | 1,872 | $307K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 24,406 | 1,584 | $2.13M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,544 | 586 | $23K |
| A4657 | Syringe, with or without needle, each | 1,401 | 720 | $22K |
| J1756 | Injection, iron sucrose, 1 mg | 1,569 | 362 | $4K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 96 | 38 | $348.30 |
| 85041 | 407 | 299 | $0.00 | |
| 83970 | 114 | 86 | $0.00 | |
| 85048 | 405 | 299 | $0.00 | |
| 83540 | 140 | 105 | $0.00 | |
| 82728 | 190 | 140 | $0.00 | |
| 90674 | 24 | 17 | $0.00 | |
| 83550 | 140 | 105 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 30 | 12 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 22 | 15 | $0.00 |